TY  - CHAP
M1  - Book, Section
TI  - Gastric Neuroendocrine Tumors
A1  - Ursem, Carling
A1  - McQuaid, Kenneth R.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Gastric  NETs  (gNETs)  make  up  less  than  1%  of  gastric  neoplasms  and  are  generally  slow-growing  tumors.  They  may  occur  sporadically  or  secondary  to  chronic  hypergastrinemia  that  results  in  hyperplasia  and  transformation  of  enterochromaffin  cells  in  the  gastric  fundus.  Based  on  clinical  characteristics,  gNETs  have  been  classified  into  four  types.  Types  1  and  2  account  for  the  majority  of  gNETs  and  are  caused  by  hypergastrinemia,  type  1  in  association  with  pernicious  anemia  (75%)  and  type  2  in  association  with  Zollinger-Ellison  syndrome  (5%).  Types  3  and  4  arise  sporadically,  are  independent  of  gastrin  production,  and  account  for  up  to  20%  of  gNETs.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/23
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193162363
ER  -